Table 2 Proportions of AVG patients with a tunneled permanent catheter and their postoperative course
No | Graft | Patient demography | Postoperative course | ||||||
|---|---|---|---|---|---|---|---|---|---|
Age | Sex | Cause of renal failure | Catheter | First cannulation | Catheter removal | Complications | Follow up | ||
1 | Propaten | 49 | M | IgA nephropathy | Bio-Flex Tesio | 36 days | 44 days | – | 956 days |
2 | Thoratec (Vectra) | 80 | F | Unknown | Split Stream | 21 days | 28 days | Stenosis (PTA) | 778 days |
3 | Advanta | 37 | M | Purpura nephritis | Split Stream | 57 days | 58 days | Seroma | 592 days |
4 | Advanta | 74 | F | Nephrosclerosis | Split Stream | 94 days | 105 days | Stenosis (PTA) | 564 days |